RT Journal Article SR Electronic T1 Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes JF Evidence Based Medicine JO Evid Based Med FD BMJ Publishing Group Ltd SP 53 OP 53 DO 10.1136/ebm.12.2.53 VO 12 IS 2 YR 2007 UL http://ebm.bmj.com/content/12/2/53.abstract AB